Anti-Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole

[1]  Jian Li,et al.  Discovery of New Imidazole Derivatives Containing the 2,4-Dienone Motif with Broad-Spectrum Antifungal and Antibacterial Activity , 2014, Molecules.

[2]  G. Gupta,et al.  Imidazoles as potential antifungal agents: a review. , 2013, Mini reviews in medicinal chemistry.

[3]  Shengzheng Wang,et al.  Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans. , 2013, FEMS yeast research.

[4]  Wei Liu,et al.  Antifungal Activity of Geldanamycin Alone or in Combination with Fluconazole Against Candida species , 2013, Mycopathologia.

[5]  K. Garey,et al.  Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches , 2012, The Annals of pharmacotherapy.

[6]  P. Chandrasekar.  Management of invasive fungal infections: a role for polyenes. , 2011, The Journal of antimicrobial chemotherapy.

[7]  R. J. Kothavade,et al.  Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. , 2010, Journal of medical microbiology.

[8]  B. Spellberg,et al.  Nosocomial fungal infections: epidemiology, diagnosis, and treatment. , 2007, Medical mycology.

[9]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[10]  D. Drucker,et al.  Effect of amphotericin B, nystatin and miconazole on the polar lipids of Candida albicans and Candida dubliniensis , 2006 .

[11]  Mercedes González,et al.  Imidazole and benzimidazole derivatives as chemotherapeutic agents. , 2005, Mini reviews in medicinal chemistry.

[12]  F. Odds,et al.  Synergy, antagonism, and what the chequerboard puts between them. , 2003, The Journal of antimicrobial chemotherapy.

[13]  N. Gow,et al.  Antifungal agents: mechanisms of action. , 2003, Trends in microbiology.

[14]  H. Kodama,et al.  Lanoconazole and Its Related Optically Active Compound NND-502: Novel Antifungal Imidazoles with a Ketene Dithioacetal Structure , 2003 .

[15]  H. Vanden Bossche,et al.  Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects. , 2003, Journal of veterinary pharmacology and therapeutics.

[16]  T. Patterson,et al.  Antifungal resistance in pathogenic fungi. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  V. Georgiev,et al.  Membrane Transporters and Antifungal Drug Resistance , 2000 .

[18]  Z. K. Khan,et al.  Antifungal agents and immunomodulators in systemic mycoses. , 2000, The Indian journal of chest diseases & allied sciences.

[19]  P. Lestage,et al.  Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones. , 2000, Journal of medicinal chemistry.

[20]  V. St. Georgiev.  Membrane transporters and antifungal drug resistance. , 2000, Current drug targets.

[21]  Holland Ib,et al.  ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. , 1999 .

[22]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  I. Holland,et al.  ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. , 1999, Journal of molecular biology.

[24]  L. Kitchen,et al.  Diethylcarbamazine-related antimicrobial activity in Mycobacterium tuberculosis-infected blood. , 1998, The Journal of antimicrobial chemotherapy.

[25]  Dominique Sanglard,et al.  Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents , 1998, Antimicrobial Agents and Chemotherapy.

[26]  H. Yamaguchi,et al.  Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent , 1995, Antimicrobial agents and chemotherapy.

[27]  Chantal Couture,et al.  Mechanisms of action , 1994, Schizophrenia Research.

[28]  B. Duerden,et al.  Comparison of the in vitro activities of fenticonazole, other imidazoles, metronidazole, and tetracycline against organisms associated with bacterial vaginosis and skin infections , 1989, Antimicrobial Agents and Chemotherapy.

[29]  D. Feingold,et al.  Effect of free fatty acids on liposome susceptibility to imidazole antifungals , 1979, Antimicrobial Agents and Chemotherapy.